A new pyrrolophenanthridone alkaloid, criasiaticidine A (1), was isolated from the bulbs of Crinum asiaticum var. japonicum, together with pratorimine (2), lycorine (3) and 4-hydroxy-7-methoxyflavan (4). The structure of the new alkaloid was determined to be 4,5-etheno-9,10-dihydroxy-6-phenanthridone by spectroscopic means. The cytotoxicity of the isolated compounds 1-4 was evaluated in vitro against Meth-A (mouse sarcoma) and Lewis lung carcinoma (mouse lung carcinoma) tumor cell lines. Furthermore, 3 was examined for in vivo antitumor activity with LLC tumor cells.
In the continuing search for antitumor compounds from natural sources, EtOAc-and alkaline EtOAc-soluble fractions of the bulbs of Crinum asiaticum var. japonicum BAKER (Amaryllidaceae) showed significant cytotoxicity, with ED 50 values of 1.1 and 0.9 mg/ml, respectively, against Lewis lung carcinoma (LLC) tumor cells. C. asiaticum var. japonicum grows wild only in Japan and Korea. 1) As regards phytochemical studies on this plant, the isolation of phenanthridine alkaloids, fatty acids, sterols and triterpene alcohols have been previously reported. [2] [3] [4] Alkaloids isolated from the bulbs of the tribe Amaryllidaceae showed various pharmacological and microbiological effects, such as antiviral, 5) antimalarial, 6 ) cytotoxic [6] [7] [8] [9] and antineoplastic activities, [10] [11] [12] as well as effects on diseases of the nervous system. 13) An EtOAc-soluble fraction of C. asiaticum var. japonicum was separated by column chromatography to afford a new pyrrolophenanthridone alkaloid, criasiaticidine A (1). Two known alkaloids, pratorimine (2) and lycorine (3) , and 4Ј-hydroxy-7-methoxyflavan (4) were also isolated. The characterization of the new alkaloid 1 and the cytotoxic activity of 1-4, as well as the in vivo antitumor activity of 3, are reported in this paper.
Results and Discussion
From EtOAc-and alkaline EtOAc-soluble fractions of the MeOH extract of the bulbs of C. asiaticum var. japonicum, three phenanthridine alkaloids and a flavan were isolated by a combination of silica gel column chromatography and reversed phase medium pressure liquid chromatography (MPLC), followed by crystallization (Chart 1). The known compounds were identified as pratorimine (2), [14] [15] [16] [17] lycorine (3), 6, 18) and 4Ј-hydroxy-7-methoxyflavan (4) 19) by comparison of the spectral properties with those reported previously.
Criasiaticidine A (1) was isolated as pale brown needles (CH 3 CN-H 2 O), mp 277-279°C. The molecular formula of 1 was assigned to be C 15 H 9 NO 3 from its molecular ion peak at m/z 251.0567 in the high-resolution electron impact mass spectrum (HR-EI-MS). The UV spectrum showing absorption bands at 225, 235, 253, 258, 296 and 345 nm indicated the presence of a pyrrolophenanthridone derivative. 20) The proton nuclear magnetic resonance spectrum ( 1 H-NMR) and carbon-13 nuclear magnetic resonance spectrum ( 13 C-NMR) data of 1 were similar to those for 2, except for the absence of a methoxy group in 1 ( Table 1) . Information for all of the functional groups and their locations in the molecule was obtained from the heteronuclear multiple-bond correlation spectrum (HMBC) (Fig. 1 (C-9), as well as between those at d H 7.79 (H-8) and d C 151.7 (C-10), confirmed the presence of two hydroxyl groups at C-9 and C-10, as shown in 1. This was further supported by the chemical shift difference of C-7 to C-11 of 1, compared with those of 2 (Table 1) , and eliminated the possibility of a methoxy substituent at either C-9 or C-10. An sp 2 methine carbon signal at d C 110.6 (C-4) showed long-range correlations with signals at d H 7.78 (H-3) and 8.06 (H-5). The former proton was further coupled with another quaternary carbon at d C 130.3 (C-11c). This suggested the presence of a nuclear indole at C-3a, 4, 5, 11c and N-6. The placement of a carbonyl carbon at C-7 was supported by the observation of long-range correlations of signals at d H 7.76 (H-11) and 7.79 (H-8) with a carbon resonance at d C 157.4. Consequently, the structure of 1 was determined to be 4,5-etheno-9,10-dihydroxy-6-phenanthridone.
Compounds 1-4 were tested for their cytotoxicity against Meth-A (mouse sarcoma) and Lewis lung carcinoma (mouse carcinoma) tumor cell lines. Compound 1 showed moderate cytotoxic effects with ED 50 values of 3.2 and 4.2 mg/ml, respectively, on Meth-A and LLC cells, and 3 showed strong cytotoxicity (ED 50 , 0.3 and 0.5 mg/ml) against both tumor cells. Compound 2 exhibited moderate activity against only Meth-A cells (ED 50 , 4.1 mg/ml), while 4 was inactive.
The cytotoxic properties of 3 agreed with those previously reported for several human and mouse tumor cell lines with ED 50 values of 0.3-1.8 mg/ml. 6, 9, [21] [22] Compound 4 has been reported to show an inhibitory effect on the incorporation of 3 H-thymidine in Molt 4 cells (child T-cell leukemia), with an IC 50 value of less than 10 mg/ml, as well as a cytotoxic effect on Molt 4 cells (ED 50 , 42 mg/ml).
7)
Compound 3 was also reported to inhibit the in vivo growth of a murine tranplantable ascites tumor. 20) Therefore, we examined the in vivo antitumor activity of lycorine with Lewis lung carcinoma tumor cells in BDF-1 mice. When the mice were treated for 2 weeks, 3 showed antitumor activity with a T/C value (tumor inhibition rate, as described in Experimental) of 80.5% at a dose of 10 mg/kg on day 19 (Table  3 and Fig. 2) . Compound 3 at a dose of 10 mg/kg maximally decreased the body weight by approximately 5% of the control, but the body weight loss was gradually improved to the range of the control after the termination of administration (Table 3) . On considering the antitumor activity and toxicity, 3 might be used as a lead to develop a potential anticancer agent.
Experimental
Melting points were measured on a Yanagiomoto micro hot-stage melting point apparatus and are not corrected. Optical rotations were measured with a DIP-360 automatic polarimeter (Jasco Co.). UV spectra were measured with a UV-2200 UV-VIS recording spectrophotometer (Shimadzu Co.). IR spectra were measured on a FT/IR-230 infrared spectrometer (Jasco Co. Korea, and dried at room temperature. A voucher specimen (CNU1005) is deposited in the herbarium of the College of Pharmacy, Chungnam National University, Taejon, Korea. Tumor Cells Meth-A (mouse sarcoma) and LLC (mouse lung carcinoma) cells were purchased from RIKEN Cell Line Bank (Tsukuba, Japan). The cells were maintained as monolayer cultures in RPMI 1640 medium supplemented with 7% fetal bovine serum, sodium bicarbonate (2 g), penicillin G (100000 units) and streptomycin (100 mg).
Isolation Procedure The minced bulbs of C. asiaticum var. japonicum (3 kg) were extracted with MeOH (10 lϫ3) to give an extract (1091 g). A part of the MeOH extract (1 kg) was suspended in H 2 O (2000 ml) and extracted with hexane (1000 mlϫ3) to give a hexane soluble fraction (21 g). The H 2 O layer was extracted with EtOAc (1000 mlϫ3, 6.9 g). The resulting H 2 O layer was basified with NH 4 OH to pH 9.0, and then extracted with EtOAc (40.2 g) and BuOH (26.7 g), respectively. Each fraction was then evaluated for cytotoxic activity against LLC tumor cells. The EtOAc-fraction (ED 50 , 1.1 mg/ml) and the basic EtOAc-fraction (ED 50 , 0.9 mg/ml) were selected for further investigation. The EtOAc-soluble fraction (6.9 g) was chromatographed on a column of silica gel (300 g). The column was eluted with a stepwise gradient of CHCl 3 and MeOH to give 4 fractions (Fr. A-D; 2.9, 1.1, 0.6 and 1.1 g, respectively) . Repeated column chromatography of Fr. A on silica gel (hexane-acetone, 4 : 1) and MPLC on RP-18 (50 and 75% aq. CH 3 CN) afforded 1 (1.5 mg), 2 (11 mg) and 4 (7.2 mg). The crude basicEtOAc fraction was dissolved in MeOH, kept overnight at room temperature, and lycorine (3, 1.5 g) was crystallized as colorless prisms.
4,5-Etheno-8,9-dihydroxy-6-phenanthridone (1, Criasiaticidine ϩ (15) with a base peak at 55.
Cytotoxicity Assay LLC cells were cultured with RPMI 1640 medium containing 7% fetal bovine serum (FBS). For sulforhodamine B (SRB) assay, 23) the cells were cultured in RPMI 1640 medium containing 7% FBS. A portion of the cell suspension (4-5ϫ10 4 cells/ml) in the culture medium was inoculated to each well of 96-well microtiter plates. One day after plating, a time zero control plate was made. Compounds were directly treated, and the cells were incubated for a further 48 h in a humidified 5% CO 2 atmosphere at 37°C. The cells were fixed with 50 ml of 50% trichloroacetic acid (TCA) solution for 1 h at 4°C, and the plates were washed 5 times with tap water and air-dried. A 50 ml sample of SRB solution (0.4% in 1% acetic acid) was added, and staining was done at room temperature for 30 min. The residual dye was washed out with 1% acetic acid, and the plates were airdried. To each well, Tris buffer solution (10 mM, pH 10.5) was added. Optical density (OD) was measured with a microtiter plate reader at 540 nm. Growth inhibition was calculated as follows: the OD of the treated well was subtracted with the OD at a time-zero (Tz) plate and divided by a calculated value of untreated control. 50% Growth inhibition of (ED 50 ) was calculated by the Probit method.
24)
Animal Specific pathogen-free female BDF-1 mice (4 weeks of age, weighing 14 to 16 g) were purchased from Japan SLC, Inc. (Shizuoka). The animals were fed a commercial pellet chow (Clea Japan Inc., Tokyo) in a temperature-controlled room at 25Ϯ2°C and water ad libitum.
Tumor Transplantation LLC cells were maintained in cell culture. A suspension of 5ϫ10 5 cells in 0.2 ml of 0.9% NaCl solution was inoculated subcutaneously into the left flank of mice for the subcutaneous tumor assay. 25) Drug Compound 3 was dissolved in 0.1 ml of 0.9 % NaCl solution, and administered intraperitoneally once daily for 2 consecutive weeks to mice.
Control animals were given 0.1 ml of a 0.9 % NaCl solution by i.p. injection.
Estimation Tumors were measured on each alternate day using a vernier caliper from the initiation of treatment to the time when gross ulceration of the tumor was developed in control mice. where a is the longest diameter and b is the shortest diameter. 26) The effects by treatments were represented by:
T/C (%)ϭ(mean value of a treated group/mean value of a control group) ϫ100
Statistical Analysis The significance of differences between the experimental groups was calculated by Dunnett's t test. pϽ0.05 was considered significant.
